Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
29,997,317
-
Total 13F shares
-
1,284,402
-
Share change
-
+986,353
-
Total reported value
-
$7,922,728
-
Put/Call ratio
-
16%
-
Price per share
-
$6.17
-
Number of holders
-
30
-
Value change
-
+$6,084,639
-
Number of buys
-
23
-
Number of sells
-
4
Institutional Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q1 2021
As of 31 Mar 2021,
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,284,402 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, Compagnie Lombard Odier SCmA, Bank of New York Mellon Corp, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.